Skip to content

Safety/Efficacy of Systane Free vs Refresh Liquigel

An Evaluation of the Safety and Efficacy of Systane Free FID 105783

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00348517
Enrollment
100
Registered
2006-07-04
Start date
2006-07-31
Completion date
2006-11-30
Last updated
2012-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Brief summary

The objective of this study is to evaluate the safety and efficacy of Systane Free FID 105783 when compared to Refresh Liquigel Lubricant Eye Drops (Allergan) in a specified population of dry eye patients.

Interventions

1-2 drops per eye four times per day for 42 days

1-2 drops per eye four times per day for 42 days

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \>/= 3 corneal staining score using NEI scoring system. * Need artificial tears at least some of the time. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* History or evidence of ocular or intraocular surgery in either eye within the past six months. * History of intolerance or hypersensitivity to any component of the study medication. * Use of Restasis within 30 days of Visit 1. * Participation in an investigational drug or device study within 30 days of entering this study. * Other protocol-defined

Design outcomes

Primary

MeasureTime frame
Change in corneal staining at Day 28 from baseline (Day 0)Day 28

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026